Aminoglycoside drugs in clinical practice: an evidence-based approach (Q37331044)

19 August 2017

1 reference

title

Aminoglycoside drugs in clinical practice: an evidence-based approach (English)

1 reference

19 August 2017

1

Leonard Leibovici

1 reference

19 August 2017

3

Mical Paul

1 reference

19 August 2017

Liat Vidal

2

1 reference

PubMed ID

19022778

19 August 2017

language of work or name

English

0 references

publication date

19 November 2008

1 reference

Journal of Antimicrobial Chemotherapy

19 August 2017

1 reference

19 August 2017

63

1 reference

19 August 2017

2

1 reference

19 August 2017

246-251

1 reference

Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study.

19 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Single versus combination intravenous antibiotic therapy for people with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Aminoglycosides for intra-abdominal infection: equal to the challenge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Extended-interval aminoglycoside administration for children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Back to the future: using aminoglycosides again and how to dose them optimally

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Molecular understanding of aminoglycoside action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN469

21 January 2018

Identifiers

DOI

10.1093/JAC/DKN469

1 reference

19 August 2017

1 reference

PubMed ID

19022778